Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Mar;11(3):131-2.
doi: 10.1038/nrneph.2014.254. Epub 2015 Jan 20.

Clinical trials. Rituximab for maintenance of remission in AAV

Affiliations
Comment

Clinical trials. Rituximab for maintenance of remission in AAV

Anisha Tanna et al. Nat Rev Nephrol. 2015 Mar.

Abstract

Maintenance therapy for antineutrophil cytoplasmic antibody-associated vasculitis (AAV) should reduce rates of relapse with minimal toxicity. The MAINRITSAN trial—the first randomized controlled trial to compare the efficacies of rituximab and azathioprine in AAV remission maintenance— has demonstrated a superior outcome using rituximab. These data have important implications for the management of AAV.

PubMed Disclaimer

Comment on

  • Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
    Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quémeneur T, Blanchard-Delaunay C, Godmer P, Puéchal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L; French Vasculitis Study Group. Guillevin L, et al. N Engl J Med. 2014 Nov 6;371(19):1771-80. doi: 10.1056/NEJMoa1404231. N Engl J Med. 2014. PMID: 25372085 Clinical Trial.

References

    1. N Engl J Med. 2014 Nov 6;371(19):1771-80 - PubMed
    1. Clin J Am Soc Nephrol. 2014 Apr;9(4):736-44 - PubMed
    1. Arthritis Rheum. 2012 Nov;64(11):3770-8 - PubMed
    1. Arthritis Rheum. 2012 Nov;64(11):3760-9 - PubMed
    1. Arthritis Rheum. 2013 Jan;65(1):1-11 - PubMed

MeSH terms

Substances

LinkOut - more resources